SFL publishes impact assessment article in European Pharmaceutical Law Review
SFL’s Associate Legal Counsel and Data Protection Officer Lorelei Garagancea
, together with Chief Scientific Officer Walter Fürst
, have published the article “Legal impact assessment of Brexit: Clinical Trials data exchange and Data Protection”
in the European Pharmaceutical Law Review. The article discusses how the current changes in policy in the EU could impact on clinical data exchange and data protection in projects involving both EU and non-EU countries, and particularly how this may affect multinational trials and programs in different Brexit scenarios.
SFL’s Legal & Compliance department offers comprehensive life sciences services to clients. Among other: legal impact assessments, GDPR compliance in clinical trials, legal classifications of combination products, medical devices and software. Please contact us
to discuss your projects.
>> SFL website